4,652 Shares in CME Group Inc. (NASDAQ:CME) Bought by Hantz Financial Services Inc.

Hantz Financial Services Inc. bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, Holdings Channel.com reports. The fund bought 4,652 shares of the financial services provider’s stock, valued at approximately $915,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CME. Norges Bank bought a new position in CME Group during the fourth quarter worth $959,260,000. Capital International Investors increased its holdings in CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. increased its holdings in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after buying an additional 1,309,097 shares during the period. Capital Wealth Planning LLC bought a new stake in CME Group in the 4th quarter valued at $253,563,000. Finally, Capital World Investors increased its holdings in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after buying an additional 1,172,575 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.8 %

Shares of NASDAQ CME opened at $215.74 on Friday. The firm’s 50-day simple moving average is $201.36 and its 200 day simple moving average is $207.43. The company has a market cap of $77.68 billion, a price-to-earnings ratio of 24.54, a price-to-earnings-growth ratio of 6.27 and a beta of 0.52. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.30 EPS. On average, research analysts expect that CME Group Inc. will post 9.8 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.13%. CME Group’s dividend payout ratio (DPR) is 52.33%.

Analyst Ratings Changes

CME has been the topic of several analyst reports. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler reissued an “overweight” rating and issued a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Barclays boosted their price target on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $213.27.

Insider Buying and Selling

In related news, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the transaction, the director now owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the transaction, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the transaction, the director now owns 14,008 shares in the company, valued at $2,821,771.52. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.